Advisor Group Holdings, Inc. Kazia Therapeutics LTD Transaction History

Advisor Group Holdings, Inc.

  • $39.8 Billion
  • Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 500 shares of KZIA stock, worth $445. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$445
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.19 - $1.24 $95 - $620
500 New
500 $0

Others Institutions Holding KZIA

# of Institutions
7
Shares Held
371K
Call Options Held
78.8K
Put Options Held
0
View Full List

About KAZIA THERAPEUTICS LTD

KZIA Quotes by TradingView
  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $13.4M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email